# Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris

> **NCT07392047** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jinnah Postgraduate Medical Centre** · enrollment: 60 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Metronidazole Topical Gel 2%
- **DRUG:** Clindamycin Topical Gel 1%

## Key facts

- **NCT ID:** NCT07392047
- **Lead sponsor:** Jinnah Postgraduate Medical Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07392047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07392047, "Metronidazole 2% Gel Versus Clindamycin 1% Gel for Moderate Acne Vulgaris". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07392047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*